resveratrol has been researched along with Haemophilus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barberán, M; Caturla, N; Díez-Martínez, R; Euba, B; Fernández-Calvet, A; Garmendia, J; López-López, N; Martí, S; Rodríguez-Arce, I | 1 |
| Bengoechea, JA; de-Torres, JP; Euba, B; Garmendia, J; Leiva, J; Moleres, J; Moranta, D; Morey, P; Segura, V; Viadas, C | 1 |
2 other study(ies) available for resveratrol and Haemophilus Infections
| Article | Year |
|---|---|
Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae.
Topics: A549 Cells; Administration, Intranasal; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; beta-Defensins; Cells, Cultured; Drug Resistance, Bacterial; Epithelial Cells; Gene Expression Regulation, Neoplastic; Haemophilus Infections; Haemophilus influenzae; Humans; Immunologic Factors; Interleukin-8; Mice; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Resveratrol; Zebrafish | 2017 |
Genome Expression Profiling-Based Identification and Administration Efficacy of Host-Directed Antimicrobial Drugs against Respiratory Infection by Nontypeable Haemophilus influenzae.
Topics: Animals; Anti-Bacterial Agents; Cell Line, Tumor; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Therapy, Combination; Enzyme Activation; Epithelial Cells; Gene Expression Profiling; Gene Expression Regulation; Genome, Human; Haemophilus Infections; Haemophilus influenzae; Host-Pathogen Interactions; Humans; Lung; Mice; Phosphodiesterase 4 Inhibitors; Respiratory Mucosa; Resveratrol; Rolipram; Signal Transduction; Sirtuin 1; Stilbenes | 2015 |